Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proton beam therapy.

W P Levin1, H Kooy, J S Loeffler

  • 1Massachusetts General Hospital Northeast Proton Therapy Center, Boston, MA 02114, USA.

British Journal of Cancer
|September 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LET<sub>d</sub> Optimization Verification With an SOI Microdosimeter.

International journal of radiation oncology, biology, physics·2024
Same author

The sacral chordoma margin.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Same author

Quality of life after resection of a chordoma of the mobile spine.

The bone & joint journal·2017
Same author

MO-F-213AB-03: Potential Reduction in Out-Of-Field Dose in Pencil Beam Scanning Proton Therapy Through Use of a Patient-Specific Aperture.

Medical physics·2017
Same author

Preoperative radiotherapy in the management of retroperitoneal liposarcoma.

The British journal of surgery·2016
Same author

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same journal

Oligometastatic neuroendocrine tumors: characteristics and prognosis.

British journal of cancer·2026
Same journal

The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.

British journal of cancer·2026
Same journal

Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

British journal of cancer·2026
Same journal

Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

British journal of cancer·2026
Same journal

Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

British journal of cancer·2026
Same journal

De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

British journal of cancer·2026
See all related articles

Proton beam radiotherapy offers superior dose distribution and no exit dose compared to conventional radiation therapy. This makes it ideal for treating tumors near critical structures and in pediatric patients, minimizing damage to healthy tissue.

Area of Science:

  • Medical Physics
  • Oncology
  • Radiation Biology

Background:

  • Conventional radiation therapy uses photons and electrons, posing risks of damage to healthy tissues and secondary malignancies.
  • Minimizing radiation-induced damage to surrounding normal tissues is a significant challenge in cancer treatment.

Purpose of the Study:

  • To highlight the advantages of proton beam radiotherapy over conventional methods.
  • To emphasize the suitability of proton therapy for specific patient populations and tumor locations.

Main Methods:

  • Review of the physical properties of proton beams compared to photons and electrons.
  • Analysis of dose distribution characteristics, including Bragg peak and absence of exit dose.
  • Evaluation of clinical applications and benefits in specific anatomical sites and pediatric cases.

Related Experiment Videos

Main Results:

  • Proton beam radiotherapy provides precise dose deposition with a finite range and no exit dose.
  • This allows for significant sparing of normal tissues beyond the tumor target.
  • Demonstrated efficacy in treating tumors adjacent to critical organs like the brain, spinal cord, and eyes.

Conclusions:

  • Proton beam radiotherapy offers improved therapeutic ratios due to superior dose distribution.
  • It is a valuable treatment option for tumors near critical structures and pediatric cancers.
  • Reduced radiation-induced toxicity and secondary malignancy risk are key benefits.